Clinical and Translational Science Core

To help meet the vision of Ending the HIV Epidemic (EHE), the Einstein-Rockefeller-CUNY Center for AIDS Research (ERC-CFAR) has formed strong collaborations both within and beyond our partner institutions, including with the New York City Department of Health and Mental Hygiene, to catalyze and support research that best serves the public’s health: to eradicate HIV infection, prevent new HIV infections, and improve the health of people living with HIV (PWH).

The overarching goal of the ERC-CFAR and the Clinical and Translational Science Core (CTSC) is to support the EHE mission by creating a broad and robust resource available to researchers locally, nationally and globally. Our synergistic partnership provides a broad range of support for clinical, translational, health services, and implementation science investigations. By leveraging the resources of the Einstein CTSA-funded Harold and Muriel Block Institute for Clinical and Translational Research, the CTSC provides access to a robust clinical database and multiple biorepositories.

For further information, please contact our study coordinator, Ms. Madeline Torres, at

Through CTSC resources, the clinical population at Montefiore/Einstein enables research at Rockefeller University, which lacks access to defined cohorts of PWH, recruiting new participants for Rockefeller’s cutting-edge research in HIV eradication. The City University of New York (CUNY) is a leader in implementation science, assessing the factors that influence our ability to impact favorably on the public’s health with interventions of proven efficacy. The CTSC is integrated into the Scientific Working Group, a driver of the ERC-CFAR’s scientific direction, to provide optimal support to the emerging research activities, and foster cross-fertilization among cores and the SWG. We will leverage Einstein’s Center for Health Data Innovations and use of state-of-the-art informatics methods, including natural language processing and machine learning, to catalyze and facilitate new research in primary prevention of HIV infection, while maintaining our extensive support of well-established research areas.

HIV Clinical Cohort Database

The Clinical Cohort Database (CCDB), derived from the Montefiore/Einstein clinical services, contains >20,000 PWH and 475,000 HIV-negative patients; >6200 PWH are in active care; 43% are women, 48% Hispanic/Latinx and 41% African American. This comprehensive, longitudinal database accesses Montefiore’s extensive clinical infrastructure and has catalyzed an explosion of clinical, epidemiologic, translational, health services, and implementation science research on HIV treatment and prevention. In addition, we facilitate enrollment of well-characterized patients (including HIV-negative controls) into new research protocols.

To propose a project utilizing the HIV Clinical Cohort Database, please complete the Collaboration Concept Sheet Submission Form. Please direct all inquiries to the study coordinator at

Recent publications supported by the Clinical, Translational and Implementation Science Core

  • *Bortnick AE, Shahid M, Shitole SG, Park M, Broder A, Rodriguez CJ, Scheuer J, Faillace R, Kizer JR (2020). Outcomes of ST‐elevation myocardial infarction by age and sex in a low‐income urban community: The Montefiore STEMI Registry. Clin Cardiol 43: 1100-1109. Pubmed
  • *Chyten-Brennan J, Patel VV, Ginsberg MS, Hanna DB (2021). Algorithm to identify transgender and gender nonbinary individuals among people living with HIV performs differently by age and ethnicity. Ann Epidemiol 54: 73- 78. Pubmed
  • *Furukawa NW, Smith DK, Gonzalez CJ, Huang YA, Hanna DB, Felsen UR, Zhu W, Arnsten JH, Patel VV (2020). Evaluation of algorithms used for PrEP surveillance using a reference population from New York City — July 2016–June 2018. Pub Health Rep 135: 202-210. Pubmed
  • Hanna DB, Ramaswamy C, Kaplan RC, Kizer JR, Daskalakis DC, Anastos K, Braunstein SL (2020). Sex- and poverty-specific patterns in HIV-associated cardiovascular mortality in New York City, 2007-2017. Clin Infect Dis 27: 491-498. Pubmed
  • *Klugman M, Fazzari M, Xue X, Ginsberg M, Rohan T, Halmos B, Hanna DB, Shuter J, Hosgood HD (2021). The associations of CD4 count, CD4/CD8 ratio, and HIV viral load with survival from non-small cell lung cancer in persons living with HIV. AIDS Care, ePub 1 Jun 2021. Pubmed
  • Kong AM, Pozen A, Anastos K, Kelvin EA, Nash D (2019). Non-HIV comorbid conditions and polypharmacy among people living with HIV age 65 or older compared with HIV-negative individuals age 65 or older in the United States: A retrospective claims-based analysis. AIDS Patient Care STDs 33: 93-103. Pubmed
  • *Patel VV, Felsen UR, Fisher M, Fazzari MJ, Ginsberg MS, Beil R, Akiyama MJ, Anastos K, Hanna DB (2021). Clinical outcomes and inflammatory markers by HIV serostatus and viral suppression in a large cohort of patients hospitalized with COVID-19. JAIDS 86: 224-230. Pubmed
  • *Shitole SG, Kuniholm MH, Hanna DB, Boucher T, Peng AY, Berardi C, Shah T, Bortnick AE, Panagiota C, Scheuer J, Kizer JR (2020). Association of human immunodeficiency virus and hepatitis C virus infection with long-term outcomes post-ST segment elevation myocardial infarction in a disadvantaged urban community. Atherosclerosis 311: 60-66. Pubmed

*Uses the HIV Clinical Cohort Database.

Complete list of publications supported by the Clinical, Translational and Implementation Science Core